These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 2470098)

  • 1. The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex.
    Barber EK; Dasgupta JD; Schlossman SF; Trevillyan JM; Rudd CE
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3277-81. PubMed ID: 2470098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD4/CD8:p56lck complex in T lymphocytes: a potential mechanism to regulate T-cell growth.
    Rudd C; Helms S; Barber EK; Schlossman SF
    Biochem Cell Biol; 1989 Sep; 67(9):581-9. PubMed ID: 2508730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syk and ZAP-70 mediate recruitment of p56lck/CD4 to the activated T cell receptor/CD3/zeta complex.
    Thome M; Duplay P; Guttinger M; Acuto O
    J Exp Med; 1995 Jun; 181(6):1997-2006. PubMed ID: 7539035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of the interaction of p56lck with the CD4 and CD8 antigens.
    Rudd CE; Barber EK; Burgess KE; Hahn JY; Odysseos AD; Sy MS; Schlossman SF
    Adv Exp Med Biol; 1991; 292():85-96. PubMed ID: 1835265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn.
    Burgess KE; Yamamoto M; Prasad KV; Rudd CE
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9311-5. PubMed ID: 1384049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular interactions, T-cell subsets and a role of the CD4/CD8:p56lck complex in human T-cell activation.
    Rudd CE; Anderson P; Morimoto C; Streuli M; Schlossman SF
    Immunol Rev; 1989 Oct; 111():225-66. PubMed ID: 2534114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p56lck SH2 domain mediates recruitment of CD8/p56lck to the activated T cell receptor/CD3/zeta complex.
    Thome M; Germain V; DiSanto JP; Acuto O
    Eur J Immunol; 1996 Sep; 26(9):2093-2100. PubMed ID: 8814252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD3-zeta surface expression is required for CD4-p56lck-mediated upregulation of T cell antigen receptor-CD3 signaling in T cells.
    Sancho J; Ledbetter JA; Choi MS; Kanner SB; Deans JP; Terhorst C
    J Biol Chem; 1992 Apr; 267(11):7871-9. PubMed ID: 1532798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The T-cell antigen CD5 acts as a receptor and substrate for the protein-tyrosine kinase p56lck.
    Raab M; Yamamoto M; Rudd CE
    Mol Cell Biol; 1994 May; 14(5):2862-70. PubMed ID: 7513045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck.
    Abraham N; Miceli MC; Parnes JR; Veillette A
    Nature; 1991 Mar; 350(6313):62-6. PubMed ID: 1706070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement for kinase activity of CD4-associated p56lck in antibody-triggered T cell signal transduction.
    Chu K; Littman DR
    J Biol Chem; 1994 Sep; 269(39):24095-101. PubMed ID: 7929062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes.
    Rudd CE; Trevillyan JM; Dasgupta JD; Wong LL; Schlossman SF
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5190-4. PubMed ID: 2455897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lymphocyte-specific protein tyrosine kinase p56lck is hyperphosphorylated on serine and tyrosine residues within minutes after activation via T cell receptor or CD2.
    Danielian S; Fagard R; Alcover A; Acuto O; Fischer S
    Eur J Immunol; 1989 Dec; 19(12):2183-9. PubMed ID: 2481585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins.
    Peri KG; Gervais FG; Weil R; Davidson D; Gish GD; Veillette A
    Oncogene; 1993 Oct; 8(10):2765-72. PubMed ID: 7690927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-linking of T-cell surface molecules CD4 and CD8 stimulates phosphorylation of the lck tyrosine protein kinase at the autophosphorylation site.
    Luo KX; Sefton BM
    Mol Cell Biol; 1990 Oct; 10(10):5305-13. PubMed ID: 2118992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coclustering CD45 with CD4 or CD8 alters the phosphorylation and kinase activity of p56lck.
    Ostergaard HL; Trowbridge IS
    J Exp Med; 1990 Jul; 172(1):347-50. PubMed ID: 2141630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed thymocyte development induced by augmented expression of p56lck.
    Abraham KM; Levin SD; Marth JD; Forbush KA; Perlmutter RM
    J Exp Med; 1991 Jun; 173(6):1421-32. PubMed ID: 1709675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56lck in human CD4 T lymphocytes.
    Hivroz C; Mazerolles F; Soula M; Fagard R; Graton S; Meloche S; Sekaly RP; Fischer A
    Eur J Immunol; 1993 Mar; 23(3):600-7. PubMed ID: 7680610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase.
    Bottino C; Vitale M; Olcese L; Sivori S; Morelli L; Augugliaro R; Ciccone E; Moretta L; Moretta A
    Eur J Immunol; 1994 Oct; 24(10):2527-34. PubMed ID: 7523145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of distinct populations of PI-3 kinase activity following T-cell activation.
    Thompson PA; Gutkind JS; Robbins KC; Ledbetter JA; Bolen JB
    Oncogene; 1992 Apr; 7(4):719-25. PubMed ID: 1373484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.